Discover our Resources
Patient support programs
Patient materials
Access programs
Product Portfolio & Product Pipeline
Diphereline®
(triptorelin embonate)
Iqirvo®
(elafibranor)
Somatuline® Autogel® (lanreotide acetate)
Our R&D strategy for a thriving product pipeline
As a global biopharmaceutical company with a focus on innovation and specialty care, Ipsen is building a strong and sustainable portfolio of medicines to meet patients’ and their healthcare teams’ needs. We prioritize best-in-class and first-in-class treatments in oncology, rare disease, and neuroscience – areas in which we have proven experience, global capabilities, and a strong network of partners.
Read More







